For the state, the cost of funding GLP-1 drugs was too high. For the patients, the cost of losing access is higher.

They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...

People struggling with their body weight experienced joy when new, more effective prescription drug options became the rage ...

Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...

Warning it is ‘not a magic bullet’, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, said: ‘Weight ...

As the NHS prepares to roll out Mounjaro for patients struggling with obesity, many eligible patients will be facing a ...

Losing weight can be a challenge for many. With so many variables present in everyday life, including stress, lack of sleep, ...

A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the ...

Weight loss jab tirzepatide – commonly sold under the brand name Mounjaro – is set to become available via the NHS for eligible patients in England. It could take up to 12 years for everyone ...

Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...

The rollout of the weight-loss drug to 3.4 million eligible patients could take up to 12 years, according to NICE.

Eli Lilly (LLY), the pharma giant that produces the popular weight-loss drug Zepbound, said it plans to test the blockbuster ...